-
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.
25 Apr 2024 07:49 GMT
… patients with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair … ). Novel hormonal therapy and taxane chemotherapy were most commonly used in …
-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer … androgen deprivation therapy in whom chemotherapy is not yet clinically indicated …
-
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical…
24 Apr 2024 20:02 GMT
… metastatic castration resistant prostate cancer have been … with metastatic castration resistant prostate cancer (mCRPC).
Presenter: … clinical development for chemotherapy-induced anemia (CIA … metastatic castration-resistant prostate cancer. This program also …
-
EC approves Astellas’ Xtandi for high-risk prostate cancer treatment
24 Apr 2024 11:23 GMT
… (BCR) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are not suitable … the early, recurrent hormone-sensitive prostate cancer setting. Astellas is in active … antibody Vyloy in combination with chemotherapy for the treatment of gastric …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer … androgen deprivation therapy in whom chemotherapy is not yet clinically indicated …
-
What Prostate Cancer Screenings Involve
23 Apr 2024 13:32 GMT
… percent more likely to get prostate cancer.
Often, getting screened just … . Feng says.
What Prostate Cancer Screening Involves
Prostate cancer screening typically involves a … such as radiation therapy, surgery, chemotherapy, immunotherapy, or other therapies.
…
-
There Are Options to Consider When Monitoring for Prostate Cancer
23 Apr 2024 11:54 GMT
… with an aggressive form of prostate cancer. Treatment, in my case … likelihood of an aggressive prostate cancer is statistically unlikely for … get a form of prostate cancer. Some less aggressive cancers … treatments like radiation and chemo or removal.
The PSA …
-
Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment
24 Apr 2024 07:54 GMT
… well as traditional chemotherapeutic drugs like doxorubicin … nanocomposites for synergistic chemo-photodynamic therapy … combinational Hyperthermia/Chemo/Chemodynamic Therapy. ACS … pyroptosis for prostate cancer self-synergistic immunotherapy. …
-
New treatment available for incurable prostate cancer
20 Apr 2024 07:41 GMT
… type of advanced prostate cancer.
In patients who have localised prostate cancer, the likelihood … it turns into castration-resistant prostate cancer, which is incurable, the … head Katja Zaletel says.
Unlike chemotherapy, the new radioactive substance, which …
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 Apr 2024 17:47 GMT
… cancer treatment. Along with chemotherapy, radiotherapy has been … postletetium metastatic gastric-resistant prostate cancer. FPI-2265 is … study of Truqap in prostate cancer, an important potential … the opportunity also in prostate cancer. And I think …